Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Multicenter Study to Compare the Efficacy of an Extended-cycle Oral Contraceptive, Seasonique [ethinylestradiol/levonorgestrel 0.03/0.15mg + ethinylestradiol 0.01mg] Which Utilizes Ethinyl Estradiol During the Usual Hormone-free Interval to Placebo for the Treatment of Cyclic Pelvic Pain in Adolescents.

Next Previous
Trial Profile

A Multicenter Study to Compare the Efficacy of an Extended-cycle Oral Contraceptive, Seasonique [ethinylestradiol/levonorgestrel 0.03/0.15mg + ethinylestradiol 0.01mg] Which Utilizes Ethinyl Estradiol During the Usual Hormone-free Interval to Placebo for the Treatment of Cyclic Pelvic Pain in Adolescents.

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 03 Nov 2021

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Most Recent Events

  • 24 May 2012 Trial phase changed from III to II, actual patient number 95 and company (Teva Pharmaceutical Industries) added as reported by ClinicalTrials.gov.
  • 07 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
  • 07 Jun 2011 Actual end date (Oct 2008) added as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top